Allurion Technologies, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Allurion Technologies, Inc. (ALUR) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 17.99 million shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-05-15
- Allurion Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 17.99M shares, a 115.71% increase year-over-year.
- Allurion Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 13.77M shares, a 500.95% increase year-over-year.
- Allurion Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 8.34M shares, a 566.57% increase year-over-year.
- Allurion Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-09-30 was 2.29M shares, a 74.35% increase year-over-year.
- Allurion Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 15.33M shares, a 220.63% increase from fiscal 2024.
- Allurion Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 4.78M shares, a 265.57% increase from fiscal 2023.
- Allurion Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 1.31M shares, a 416.87% increase from fiscal 2022.
- Allurion Technologies, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 253.01K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 17.99M shares 10-Q · filed 2026-05-15 | |||||||
| 2025-12-31 | 15.33M shares 10-K · filed 2026-03-30 | |||||||
| 2025-09-30 | 13.77M shares 10-Q · filed 2025-11-17 | 13.77M shares 10-Q · filed 2025-11-17 | ||||||
| 2025-06-30 | 13.94M shares 10-Q · filed 2025-08-19 | |||||||
| 2025-03-31 | 8.34M shares 10-Q · filed 2026-05-15 | 7.10M shares 10-Q · filed 2025-05-15 | ||||||
| 2024-12-31 | 4.78M shares 10-K · filed 2026-03-30 | |||||||
| 2024-09-30 | 2.29M shares 10-Q · filed 2025-11-17 | 2.03M shares 10-Q · filed 2025-11-17 | 57.37M shares 10-Q · filed 2024-11-13 | |||||
| 2024-06-30 | 1.46M shares 10-Q/A · filed 2025-08-28 | 36.43M shares 10-Q · filed 2024-08-14 | 1.46M shares 10-Q/A · filed 2025-08-28 | 35.28M shares 10-Q · filed 2024-08-14 | ||||
| 2024-03-31 | 1.25M shares 10-Q/A · filed 2025-08-28 | 31.28M shares 10-Q · filed 2024-05-14 | ||||||
| 2023-12-31 | 1.31M shares 10-K/A · filed 2025-08-28 | 32.69M shares 10-K · filed 2024-03-26 | ||||||
| 2023-09-30 | 1.31M shares 10-Q/A · filed 2025-08-28 | 1.31M shares 10-Q/A · filed 2025-08-28 | 32.86M shares 10-Q · filed 2023-11-14 | |||||
| 2023-06-30 | 378.95K shares 10-Q/A · filed 2025-08-28 | 9.47M shares 10-Q · filed 2024-08-14 | 378.95K shares 10-Q/A · filed 2025-08-28 | 29.60M shares 10-Q · filed 2023-10-20 | ||||
| 2023-03-31 | 346.97K shares 10-Q/A · filed 2025-08-28 | 8.67M shares 10-Q · filed 2024-05-14 | ||||||
| 2022-12-31 | 253.01K shares 10-K/A · filed 2025-08-28 | 6.33M shares 10-K · filed 2024-03-26 | ||||||
| 2022-09-30 | 3.51M shares 10-Q · filed 2023-11-14 | |||||||
| 2022-06-30 | 23.56M shares 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |